Amikacin is available under several brand names, with Amikin being the most recognized [1]. Other brand names for amikacin include Amiklin and Biclin [2].
What is Amikacin used to treat?
Amikacin is an aminoglycoside antibiotic used to treat serious bacterial infections [3]. It is particularly effective against many Gram-negative bacteria, including strains resistant to other antibiotics like gentamicin and tobramycin [3]. Infections commonly treated with amikacin include those of the respiratory tract, urinary tract, skin and soft tissues, and intra-abdominal infections [3].
How does Amikacin work?
Amikacin works by inhibiting bacterial protein synthesis [3]. It binds to the 30S ribosomal subunit of bacteria, interfering with the decoding of mRNA and causing the production of non-functional or toxic proteins, ultimately leading to bacterial cell death [3].
What are the potential side effects of Amikacin?
Like other aminoglycosides, amikacin carries risks, primarily affecting the kidneys and hearing [3]. Potential side effects include nephrotoxicity (kidney damage) and ototoxicity (damage to the inner ear, which can lead to hearing loss or balance problems) [3]. These risks are typically dose-dependent and can be influenced by the duration of treatment [3]. Other side effects may include neuromuscular blockade, neurotoxicity, and hypersensitivity reactions [3].
When does Amikacin's patent exclusivity expire?
Information regarding the specific patent expiry dates for amikacin brand names is complex due to the drug's long history and potential for multiple patents covering different aspects of its formulation or use [4]. However, as a well-established antibiotic, the original patents for amikacin have long expired, allowing for generic versions to be available [4]. For detailed patent information on specific amikacin products, resources like DrugPatentWatch.com can be consulted [4].
Can generic versions of Amikacin be produced?
Yes, generic versions of amikacin are available because the original patents have expired [4]. The availability of generics generally leads to lower treatment costs.
How does Amikacin compare to other aminoglycosides?
Amikacin is a semi-synthetic aminoglycoside developed to overcome resistance mechanisms seen with older drugs like gentamicin and tobramycin [3]. While sharing a similar mechanism of action and potential for nephrotoxicity and ototoxicity, amikacin often retains activity against bacteria that have developed resistance to other aminoglycosides [3].
Who manufactures Amikacin?
Amikacin is manufactured by various pharmaceutical companies globally. Brands like Amikin were historically associated with Bristol-Myers Squibb [1]. Generic formulations are produced by numerous pharmaceutical manufacturers.
What clinical data supports Amikacin's use?
Clinical trials have demonstrated the efficacy of amikacin in treating a wide range of serious bacterial infections, often in combination with other antibiotics, particularly when dealing with multi-drug resistant Gram-negative organisms [3]. Its use is guided by susceptibility testing to ensure effectiveness against the specific pathogen involved [3].
What are patient concerns regarding Amikacin treatment?
Patients are typically concerned about the potential for serious side effects, particularly hearing loss and kidney damage [3]. Monitoring of kidney function and hearing is often recommended during amikacin therapy to detect and manage these risks [3].
---
Sources:
[1] https://www.drugpatentwatch.com/brand-drug/amikin
[2] https://www.drugpatentwatch.com/drug/amikacin
[3] https://www.ncbi.nlm.nih.gov/books/NBK557473/
[4] https://www.drugpatentwatch.com/